Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, characterized by lack of estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth receptor type 2 (HER2) expression. Here, ESR1 is linked to triple-negative breast carcinoma.